Besifloxacin HCl Ophthalmic In situ Gel: Design, Optimization, In vitro and Ex vivo Investigation

The present work aimed to formulate and evaluate Besifloxacin Hydrochloride (HCl) ophthalmic in situ gel for conjunctivitis, based on temperature triggered gelation system to increase ocular residence time, bioavailability and patient compliance. Different formulations were prepared by using Poloxam...

Full description

Saved in:
Bibliographic Details
Published in:Research journal of pharmacy and technology 2024-05, Vol.17 (5), p.2035-2039
Main Authors: Desai, Aparna, Pagariya, Ashish, Rathod, Monika, Kayande, Kalyani, Chhajed, Mahavir, Deokar, Rushali, Rai, Sudhish
Format: Article
Language:English
Subjects:
Bioavailability
Cold
Cornea
Drug delivery systems
E coli
Histopathology
Patient compliance
Phase transitions
Physiology
Rheology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present work aimed to formulate and evaluate Besifloxacin Hydrochloride (HCl) ophthalmic in situ gel for conjunctivitis, based on temperature triggered gelation system to increase ocular residence time, bioavailability and patient compliance. Different formulations were prepared by using Poloxamer 407 and Poloxamer 188 as temperature sensitive as well as mucoadhesive polymers. Design expert software version 11 was used to optimized the formula. Optimized batch having Poloxamer 407 (24.80% w/v) and Poloxamer 188 (14.53% w/v) was evaluated for visual appearance, clarity, gelation temperature, gelling capacity, rheological property, ex vivo, in vitro release and accelerated stability studies. Histopathological study was carried out using Goat cornea and revealed no change in histopathology of the tissues. Formulation was found to be effective against the Escherichia coli and Staphylococcus aureus. Cumulative % drug release of Besifloxacin HCl ophthalmic in situ gel after 8 hours was found to be 96.47 %.
ISSN:0974-3618
0974-360X
0974-306X
DOI:10.52711/0974-360X.2024.00322